04/23/2025
“Acting Governor Tahesha Way today signed legislation requiring State-regulated health insurers to cover biomarker testing, putting this form of diagnostic testing in reach for more New Jerseyans.
Biomarker testing analyzes an individual’s unique biological indicators to provide insights into their health status or risk of certain diseases like cancer. Biomarkers can inform certain treatment plans, making this form of testing a critical step to applying precision medicine and targeted therapies that can improve health outcomes and provide for better quality of life.
Under the bill, state-regulated health insurance providers, Medicaid, and the SHBP and SEHBP are required to provide coverage for biomarker testing for the purposes of diagnosis, treatment, appropriate management, or ongoing monitoring of an individual’s disease or condition when the test is supported by medical and scientific evidence.
“The New Jersey State Society of Physician Assistants (NJSSPA) extends our sincere gratitude to Governor Phil Murphy and Lieutenant Governor Tahesha Way for signing the biomarker testing bill (A4163/S3098) into law,” said Victoria Latella, President of NJSSPA. “This critical legislation advances timely, equitable access to precision diagnostics that are essential for identifying the most effective treatments for patients. As frontline providers in team-based care, physician assistants play a vital role in delivering these advanced diagnostic and treatment options to patients. This law empowers healthcare teams across the state to make more informed, personalized decisions that improve outcomes and enhance the quality of care. NJSSPA is proud to have stood alongside advocates and lawmakers, particularly the bill’s sponsors, Senator Gopal and Assemblywoman Sumter, to make this possible.””
https://www.nj.gov/governor/news/news/562025/approved/20250423b.shtml